bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
3.920
-0.060 (-1.51%)
At close: Apr 2, 2026, 4:00 PM EDT
3.770
-0.150 (-3.83%)
After-hours: Apr 2, 2026, 7:59 PM EDT

bioAffinity Technologies Revenue

In the year 2025, bioAffinity Technologies had annual revenue of $6.16M, down -34.18%. bioAffinity Technologies had revenue of $1.59M in the quarter ending December 31, 2025, a decrease of -27.85%.

Revenue (ttm)
$6.16M
Revenue Growth
-34.18%
P/S Ratio
2.86
Revenue / Employee
$108,105
Employees
57
Market Cap
17.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.16M-3.20M-34.18%
Dec 31, 20249.36M6.83M269.68%
Dec 31, 20232.53M2.53M52,627.44%
Dec 31, 20224.80K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inotiv514.03M
MDxHealth107.88M
FONAR106.03M
Exagen66.58M
XWELL29.21M
Precipio24.05M
Insight Molecular Diagnostics4.06M
Mainz Biomed1.07M
Revenue Rankings